HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guillermo De Velasco Selected Research

Guillermo De Velasco Research Topics

Disease

14Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 05/2013
6Neoplasms (Cancer)
01/2020 - 08/2016
2Exanthema (Rash)
01/2017 - 08/2016
2Disease Progression
01/2017 - 08/2016
1Colitis
01/2017
1Pneumonia (Pneumonitis)
01/2017
1Neoplasm Metastasis (Metastasis)
01/2017
1Hypothyroidism
01/2017
1Mental Disorders (Mental Disorder)
08/2016
1Pruritus (Itching)
08/2016
1Anorexia
08/2016
1Prostatic Neoplasms (Prostate Cancer)
04/2016
1Diabetes Mellitus
04/2016
1Cognitive Dysfunction
04/2016
1Venous Thromboembolism
04/2016
1Peripheral Arterial Disease
04/2016
1Hypoxia (Hypoxemia)
03/2016

Drug/Important Bio-Agent (IBA)

4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 02/2016
4Sunitinib (Sutent)FDA Link
01/2021 - 05/2013
3IpilimumabIBA
09/2019 - 01/2017
3Immune Checkpoint InhibitorsIBA
01/2018 - 01/2017
2NivolumabIBA
09/2019 - 01/2019
2Phosphotransferases (Kinase)IBA
08/2016 - 03/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1LigandsIBA
01/2018
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2017
1Bevacizumab (Avastin)FDA Link
08/2016
1NVP-BKM120IBA
08/2016
1Lipase (Acid Lipase)FDA Link
08/2016
1AmylasesFDA Link
08/2016
1TOR Serine-Threonine KinasesIBA
08/2016
1AndrogensIBA
04/2016
1RNA (Ribonucleic Acid)IBA
03/2016
1DNA (Deoxyribonucleic Acid)IBA
03/2016
1Proteins (Proteins, Gene)FDA Link
03/2016
1Biomarkers (Surrogate Marker)IBA
05/2013

Therapy/Procedure

13Therapeutics
01/2021 - 05/2013
1Time-to-Treatment
01/2020
1Duration of Therapy
01/2020
1Orchiectomy (Orchidectomy)
04/2016
1Castration
04/2016